Financhill
Buy
60

NN Quote, Financials, Valuation and Earnings

Last price:
$12.18
Seasonality move :
7.68%
Day range:
$12.15 - $13.07
52-week range:
$6.47 - $18.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
258.56x
P/B ratio:
31.92x
Volume:
1.7M
Avg. volume:
1.5M
1-year change:
84.95%
Market cap:
$1.6B
Revenue:
$5.7M
EPS (TTM):
-$0.85
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $569K $763K $3.9M $3.9M $5.7M
Revenue Growth (YoY) -- 34.1% 414.55% -1.63% 46.79%
 
Cost of Revenues $7.8M $18.4M $11.8M $12.7M $10.8M
Gross Profit -$7.2M -$17.6M -$7.9M -$8.9M -$5.1M
Gross Profit Margin -1265.55% -2310.22% -200.71% -229.96% -90.1%
 
R&D Expenses $8.8M $9.5M $17.1M $19.5M $16.2M
Selling, General & Admin $13.3M $13.6M $36.9M $30.3M $33.5M
Other Inc / (Exp) -$97.8M -$84.3M $24.5M -$4.3M -$32.2M
Operating Expenses $22.3M $24.8M $57.7M $54.6M $55M
Operating Income -$29.5M -$42.4M -$65.5M -$63.5M -$60.1M
 
Net Interest Expenses $10M $17.8M -- $3.7M $9.4M
EBT. Incl. Unusual Items -$137.3M -$144.6M -$40.1M -$71.5M -$101.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $38K $52K -$28K $221K $173K
Net Income to Company -$137.3M -$144.7M -$40.1M -$71.7M -$101.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$137.3M -$144.7M -$40.1M -$71.7M -$101.9M
 
Basic EPS (Cont. Ops) -$1.78 -$6.73 -$0.40 -$0.66 -$0.84
Diluted EPS (Cont. Ops) -$1.78 -$6.73 -$0.40 -$0.66 -$0.84
Weighted Average Basic Share $95.5M $23.6M $101M $108M $121.5M
Weighted Average Diluted Share $95.5M $23.6M $101M $108M $121.5M
 
EBITDA -$127M -$40.6M -$61.9M -$58.7M -$54.9M
EBIT -$127.3M -$42.4M -$65.5M -$63.5M -$60.1M
 
Revenue (Reported) $569K $763K $3.9M $3.9M $5.7M
Operating Income (Reported) -$29.5M -$42.4M -$65.5M -$63.5M -$60.1M
Operating Income (Adjusted) -$127.3M -$42.4M -$65.5M -$63.5M -$60.1M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- $20K $803K $1.2M $1.9M
Revenue Growth (YoY) -- -- 3915% 50.06% 58.59%
 
Cost of Revenues -- $6.7M $2.9M $3.3M $2.5M
Gross Profit -- -$6.7M -$2.1M -$2.1M -$596K
Gross Profit Margin -- -33510% -265.88% -177.68% -31.19%
 
R&D Expenses -- $2.6M $4.3M $4.9M $3.9M
Selling, General & Admin -- $4.2M $7.1M $11.6M $8.9M
Other Inc / (Exp) -- -$23.1M $1.5M $5.6M -$14.8M
Operating Expenses -- $7.5M $12.4M $17.8M $14.2M
Operating Income -- -$14.2M -$14.5M -$19.9M -$14.8M
 
Net Interest Expenses -- $8.9M -- $2.1M $2.7M
EBT. Incl. Unusual Items -- -$46.2M -$12.6M -$16.3M -$32.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $12K -$69K $62K $35K
Net Income to Company -- -$46.2M -$12.5M -$16.4M -$32.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -$46.2M -$12.5M -$16.4M -$32.3M
 
Basic EPS (Cont. Ops) -- -$0.48 -$0.12 -$0.15 -$0.25
Diluted EPS (Cont. Ops) -- -$0.48 -$0.12 -$0.15 -$0.25
Weighted Average Basic Share -- $96.5M $108.6M $109.4M $129.1M
Weighted Average Diluted Share -- $96.5M $108.6M $109.4M $129.1M
 
EBITDA -- -$13.4M -$13.5M -$8.7M $4M
EBIT -- -$14.2M -$14.5M -$10M $2.7M
 
Revenue (Reported) -- $20K $803K $1.2M $1.9M
Operating Income (Reported) -- -$14.2M -$14.5M -$19.9M -$14.8M
Operating Income (Adjusted) -- -$14.2M -$14.5M -$10M $2.7M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- $763K $3.9M $3.9M $5.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $18.4M $11.8M $12.7M $10.8M
Gross Profit -- -$17.6M -$7.9M -$8.9M -$5.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $9.5M $17.1M $19.5M $16.2M
Selling, General & Admin -- $13.6M $36.9M $30.3M $33.5M
Other Inc / (Exp) -- -$84.3M $24.5M -$4.3M -$32.2M
Operating Expenses -- $24.8M $57.7M $54.6M $55M
Operating Income -- -$42.4M -$65.5M -$63.5M -$60.1M
 
Net Interest Expenses -- $17.8M -- $3.7M $9.4M
EBT. Incl. Unusual Items -- -$144.6M -$40.1M -$71.5M -$101.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $51K -$28K $221K $173K
Net Income to Company -- -$144.7M -$40.1M -$71.7M -$101.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -$144.7M -$40.1M -$71.7M -$101.9M
 
Basic EPS (Cont. Ops) -- -$1.65 -$0.39 -$0.66 -$0.85
Diluted EPS (Cont. Ops) -- -$1.65 -$0.39 -$0.66 -$0.85
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -$52.3M -$61.9M -$55.6M -$34.9M
EBIT -- -$54.1M -$65.5M -$60.4M -$40.2M
 
Revenue (Reported) -- $763K $3.9M $3.9M $5.7M
Operating Income (Reported) -- -$42.4M -$65.5M -$63.5M -$60.1M
Operating Income (Adjusted) -- -$54.1M -$65.5M -$60.4M -$40.2M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $763K $3.9M $3.9M $5.7M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $18.4M $11.8M $12.7M $10.8M --
Gross Profit -$17.6M -$7.9M -$8.9M -$5.1M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $9.5M $17.1M $19.5M $16.2M --
Selling, General & Admin $13.6M $36.9M $30.3M $33.5M --
Other Inc / (Exp) -$84.3M $24.5M -$4.3M -$32.2M --
Operating Expenses $24.8M $57.7M $54.6M $55M --
Operating Income -$42.4M -$65.5M -$63.5M -$60.1M --
 
Net Interest Expenses $17.8M -- $4.1M $9.4M --
EBT. Incl. Unusual Items -$144.6M -$40.1M -$71.5M -$101.7M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $51K -$28K $221K $173K --
Net Income to Company -$144.7M -$40.1M -$71.7M -$101.9M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$144.7M -$40.1M -$71.7M -$101.9M --
 
Basic EPS (Cont. Ops) -$1.65 -$0.39 -$0.66 -$0.85 --
Diluted EPS (Cont. Ops) -$1.65 -$0.39 -$0.66 -$0.85 --
Weighted Average Basic Share $383M $411.9M $430.6M $481.8M --
Weighted Average Diluted Share $383M $413.2M $430.6M $481.8M --
 
EBITDA -$52.3M -$61.9M -$55.6M -$34.9M --
EBIT -$54.1M -$65.5M -$60.4M -$40.2M --
 
Revenue (Reported) $763K $3.9M $3.9M $5.7M --
Operating Income (Reported) -$42.4M -$65.5M -$63.5M -$60.1M --
Operating Income (Adjusted) -$54.1M -$65.5M -$60.4M -$40.2M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $8.7M $100.1M $47.2M $81.9M $39.3M
Short Term Investments -- -- $8.2M $4M $40.8M
Accounts Receivable, Net $77K $1.7M $2.2M $2.3M $3.3M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $4.3M $4.5M $3.6M $3.1M $2.6M
Total Current Assets $18.1M $106.3M $61.2M $91.2M $86M
 
Property Plant And Equipment $5.7M $21.8M $32.9M $40.8M $35.3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- $17.5M $18M $17M
Other Intangibles $4.1M $4.1M $10.4M $10.6M $9.6M
Other Long-Term Assets $17M $4.6M $1.8M $1.5M $13.8M
Total Assets $44.9M $136.8M $123.8M $162.2M $161.7M
 
Accounts Payable $680K $448K $1M $391K $858K
Accrued Expenses $3.6M $4.6M $5.2M $6.6M $8.5M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- $2.5M $2.5M $2.5M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.2M $6.7M $8.9M $9.8M $12.1M
 
Long-Term Debt $58.9M -- -- $48.4M $54.6M
Capital Leases -- -- -- -- --
Total Liabilities $535.3M $36.9M $19.9M $82.1M $111.6M
 
Common Stock $2K $11K $12K $12K $14K
Other Common Equity Adj -- -$121K $1.4M $2.2M $665K
Common Equity -$490.4M $100M $100M $78.7M $50.1M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $3.8M $1.4M --
Total Equity -$490.4M $100M $103.9M $80.1M $50.1M
 
Total Liabilities and Equity $44.9M $136.8M $123.8M $162.2M $161.7M
Cash and Short Terms $8.7M $100.1M $55.4M $85.8M $80.1M
Total Debt $58.9M -- -- $48.4M $54.6M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents -- $100.1M $47.2M $81.9M $39.3M
Short Term Investments -- -- $8.2M $4M $40.8M
Accounts Receivable, Net -- $1.7M $2.2M $2.3M $3.3M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- $4.5M $3.6M $3.1M $2.6M
Total Current Assets -- $106.3M $61.2M $91.2M $86M
 
Property Plant And Equipment -- $21.8M $32.9M $40.8M $35.3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- $17.5M $18M $17M
Other Intangibles -- $4.1M $10.4M $10.6M $9.6M
Other Long-Term Assets -- $4.6M $1.8M $1.5M $13.8M
Total Assets -- $136.8M $123.8M $162.2M $161.7M
 
Accounts Payable -- $448K $1M $391K $858K
Accrued Expenses -- $4.6M $5.2M $6.6M $8.5M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- $2.5M $2.5M $2.5M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- $6.7M $8.9M $9.8M $12.1M
 
Long-Term Debt -- -- -- $48.4M $54.6M
Capital Leases -- -- -- -- --
Total Liabilities -- $36.9M $19.9M $82.1M $111.6M
 
Common Stock -- $11K $12K $12K $14K
Other Common Equity Adj -- -$121K $1.4M $2.2M $665K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $3.8M $1.4M --
Total Equity -- $100M $103.9M $80.1M $50.1M
 
Total Liabilities and Equity -- $136.8M $123.8M $162.2M $161.7M
Cash and Short Terms -- $100.1M $55.4M $85.8M $80.1M
Total Debt -- -- -- $48.4M $54.6M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$137.3M -$144.7M -$40.1M -$71.7M -$101.9M
Depreciation & Amoritzation $235K $1.8M $3.7M $4.8M $5.2M
Stock-Based Compensation $7.4M $1.7M $26.5M $21.8M $13.9M
Change in Accounts Receivable -$860K -$1.7M -$428K -$164K -$969K
Change in Inventories -- -- -- -- --
Cash From Operations -$28.4M -$47.9M -$37.1M -$35.4M -$38M
 
Capital Expenditures $7.2M $1.3M $3.6M $3.7M $792K
Cash Acquisitions -- -- -$4M -- --
Cash From Investing -$7.2M -$1.3M -$15.7M $1.1M -$39.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $40.3M $24.6M -- $70M --
Long-Term Debt Repaid -- -$96.9M -$17K -$110K -$111K
Repurchase of Common Stock -- -- -$4K -- --
Other Financing Activities -$5.5M $207.9M -- -$1.9M $40K
Cash From Financing $34.8M $135.6M $43K $69M $35.1M
 
Beginning Cash (CF) $14.5M $13.7M $100.1M $47.2M $81.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$812K $86.4M -$52.8M $34.6M -$42.4M
Ending Cash (CF) $13.7M $100.1M $47.2M $81.9M $39.3M
 
Levered Free Cash Flow -$35.6M -$49.2M -$40.7M -$39.2M -$38.8M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -- -$46.2M -$12.5M -$16.4M -$32.3M
Depreciation & Amoritzation -- $713K $1M $1.3M $1.3M
Stock-Based Compensation -- $642K $5.9M $9.2M $2.7M
Change in Accounts Receivable -- -$1.7M -$726K $405K -$1.1M
Change in Inventories -- -- -- -- --
Cash From Operations -- -$18.5M -$11.9M -$10.8M -$11.9M
 
Capital Expenditures -- $228K $1.6M $485K $256K
Cash Acquisitions -- -- -$2.9M -- --
Cash From Investing -- -$228K -$4.4M $2.6M -$21.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $6.2M -- -- --
Long-Term Debt Repaid -- -- -$17K -$28K -$29K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- $117.2M -$1K -$21K $5.4M
 
Beginning Cash (CF) -- $1.6M $63.6M $90.1M $67.9M
Foreign Exchange Rate Adjustment -- -$6K -$8K $32K -$189K
Additions / Reductions -- $98.4M -$16.4M -$8.3M -$28.4M
Ending Cash (CF) -- $100.1M $47.2M $81.9M $39.3M
 
Levered Free Cash Flow -- -$18.7M -$13.5M -$11.3M -$12.2M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -- -$144.7M -$40.1M -$71.7M -$101.9M
Depreciation & Amoritzation -- $1.8M $3.7M $4.8M $5.2M
Stock-Based Compensation -- $1.7M $26.5M $21.8M $13.9M
Change in Accounts Receivable -- -$1.7M -$428K -$164K -$969K
Change in Inventories -- -- -- -- --
Cash From Operations -- -$47.9M -$37.1M -$35.4M -$38M
 
Capital Expenditures -- $1.3M $3.6M $3.7M $792K
Cash Acquisitions -- -- -$4M -- --
Cash From Investing -- -$1.3M -$15.7M $1.1M -$39.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $24.6M -- -- --
Long-Term Debt Repaid -- -- -$17K -$110K -$111K
Repurchase of Common Stock -- -- -$4K -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- $135.6M $43K $69M $35.1M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- $86.4M -$52.8M $34.6M -$42.4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -$49.2M -$40.7M -$39.2M -$38.8M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$144.7M -$40.1M -$71.7M -$101.9M --
Depreciation & Amoritzation $1.8M $3.7M $4.8M $5.2M --
Stock-Based Compensation $1.7M $26.5M $21.8M $13.9M --
Change in Accounts Receivable -$1.7M -$428K -$164K -$969K --
Change in Inventories -- -- -- -- --
Cash From Operations -$47.9M -$37.1M -$35.4M -$38M --
 
Capital Expenditures $1.3M $3.6M $3.7M $792K --
Cash Acquisitions -- -$4M -- -- --
Cash From Investing -$1.3M -$15.7M $1.1M -$39.5M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $24.6M -- $70M -- --
Long-Term Debt Repaid -- -$17K -$110K -$111K --
Repurchase of Common Stock -- -$4K -- -- --
Other Financing Activities -- -- -$1.9M $40K --
Cash From Financing $135.6M $43K $69M $35.1M --
 
Beginning Cash (CF) $35.4M $340M $234M $286.1M --
Foreign Exchange Rate Adjustment -$20K -$58K $30K -$176K --
Additions / Reductions $86.4M -$52.8M $34.6M -$42.4M --
Ending Cash (CF) $121.8M $287.1M $268.6M $243.5M --
 
Levered Free Cash Flow -$49.2M -$40.7M -$39.2M -$38.8M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is down 15.72% over the past day.

Sell
16
PCVX alert for Apr 1

Vaxcyte [PCVX] is down 2.73% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is down 4.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock